Autopsy report · NCT00809341
R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Cause of deathSlow enrollment
“Low accrual”
Life of this trial
- Ran for about 5 years 3 months before it stopped.
- 27 participants enrolled.
- Results were posted on the registry 4 years 5 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Sponsor type
- University, hospital or other
- Conditions
- Non-Hodgkin's Lymphoma
- Interventions
- Rituximab; Cyclophosphamide; Doxorubicin; Vincristine; Prednisone; Ifosfamide
- Participants
- 27
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.